These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 20740675)
1. Controlled drug delivery system based on ordered mesoporous silica matrices of captopril as angiotensin-converting enzyme inhibitor drug. Popovici RF; Seftel EM; Mihai GD; Popovici E; Voicu VA J Pharm Sci; 2011 Feb; 100(2):704-14. PubMed ID: 20740675 [TBL] [Abstract][Full Text] [Related]
2. In vitro controlled release of antihypertensive drugs intercalated into unmodified SBA-15 and MgO modified SBA-15 matrices. Alexa IF; Ignat M; Popovici RF; Timpu D; Popovici E Int J Pharm; 2012 Oct; 436(1-2):111-9. PubMed ID: 22743006 [TBL] [Abstract][Full Text] [Related]
3. Effective controlled release of captopril by silylation of mesoporous MCM-41. Qu F; Zhu G; Huang S; Li S; Qiu S Chemphyschem; 2006 Feb; 7(2):400-6. PubMed ID: 16411260 [TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of glycidyl methacrylate organo bridges grafted mesoporous silica SBA-15 as ibuprofen and mesalamine carrier for controlled release. Rehman F; Rahim A; Airoldi C; Volpe PLO Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():970-979. PubMed ID: 26652455 [TBL] [Abstract][Full Text] [Related]
5. Formulation and In Vitro Characterization of Bioactive Mesoporous Silica with Doxorubicin and Metronidazole Intended for Bone Treatment and Regeneration. Czarnobaj K; Prokopowicz M; Sawicki W AAPS PharmSciTech; 2017 Nov; 18(8):3163-3171. PubMed ID: 28534298 [TBL] [Abstract][Full Text] [Related]
6. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique. Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738 [TBL] [Abstract][Full Text] [Related]
7. Study of mesoporous silica/magnetite systems in drug controlled release. Souza KC; Ardisson JD; Sousa EM J Mater Sci Mater Med; 2009 Feb; 20(2):507-12. PubMed ID: 18839283 [TBL] [Abstract][Full Text] [Related]
8. Optimization of tetracycline hydrochloride adsorption on amino modified SBA-15 using response surface methodology. Hashemikia S; Hemmatinejad N; Ahmadi E; Montazer M J Colloid Interface Sci; 2015 Apr; 443():105-14. PubMed ID: 25540827 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, amino-functionalization of mesoporous silica and its adsorption of Cr(VI). Li J; Miao X; Hao Y; Zhao J; Sun X; Wang L J Colloid Interface Sci; 2008 Feb; 318(2):309-14. PubMed ID: 18036539 [TBL] [Abstract][Full Text] [Related]
10. Functionalized SBA-15 materials as carriers for controlled drug delivery: influence of surface properties on matrix-drug interactions. Song SW; Hidajat K; Kawi S Langmuir; 2005 Oct; 21(21):9568-75. PubMed ID: 16207037 [TBL] [Abstract][Full Text] [Related]
11. Adsorption of lysozyme on hyaluronic acid functionalized SBA-15 mesoporous silica: a possible bioadhesive depot system. Medda L; Casula MF; Monduzzi M; Salis A Langmuir; 2014 Nov; 30(43):12996-3004. PubMed ID: 25295387 [TBL] [Abstract][Full Text] [Related]
12. Luminescence functionalization of SBA-15 by YVO4:Eu3+ as a novel drug delivery system. Yang P; Huang S; Kong D; Lin J; Fu H Inorg Chem; 2007 Apr; 46(8):3203-11. PubMed ID: 17371013 [TBL] [Abstract][Full Text] [Related]
13. A stand-alone mesoporous crystal structure model from in situ X-ray diffraction: nitrogen adsorption on 3D cagelike mesoporous silica SBA-16. Miyasaka K; Hano H; Kubota Y; Lin Y; Ryoo R; Takata M; Kitagawa S; Neimark AV; Terasaki O Chemistry; 2012 Aug; 18(33):10300-11. PubMed ID: 22829334 [TBL] [Abstract][Full Text] [Related]
14. Preparation of efficient quercetin delivery system on Zn-modified mesoporous SBA-15 silica carrier. Trendafilova I; Szegedi A; Mihály J; Momekov G; Lihareva N; Popova M Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():285-292. PubMed ID: 28183610 [TBL] [Abstract][Full Text] [Related]
15. Nanostructure-loaded mesoporous silica for controlled release of coumarin derivatives: a novel testing of the hyperthermia effect. Al-Kady AS; Gaber M; Hussein MM; Ebeid el-ZM Eur J Pharm Biopharm; 2011 Jan; 77(1):66-74. PubMed ID: 20974253 [TBL] [Abstract][Full Text] [Related]
16. Dissolution enhancement of a model poorly water-soluble drug, atorvastatin, with ordered mesoporous silica: comparison of MSF with SBA-15 as drug carriers. Maleki A; Hamidi M Expert Opin Drug Deliv; 2016; 13(2):171-81. PubMed ID: 26636904 [TBL] [Abstract][Full Text] [Related]
17. Ordered mesoporous silica modified with lanthanum for ibuprofen loading and release behaviour. Goscianska J; Olejnik A; Nowak I; Marciniak M; Pietrzak R Eur J Pharm Biopharm; 2015 Aug; 94():550-8. PubMed ID: 26170160 [TBL] [Abstract][Full Text] [Related]
18. L-Trp adsorption into silica mesoporous materials to promote bone formation. Balas F; Manzano M; Colilla M; Vallet-Regí M Acta Biomater; 2008 May; 4(3):514-22. PubMed ID: 18234569 [TBL] [Abstract][Full Text] [Related]
19. Functionalized silica nanoparticles as a carrier for Betamethasone Sodium Phosphate: Drug release study and statistical optimization of drug loading by response surface method. Ghasemnejad M; Ahmadi E; Mohamadnia Z; Doustgani A; Hashemikia S Mater Sci Eng C Mater Biol Appl; 2015 Nov; 56():223-32. PubMed ID: 26249584 [TBL] [Abstract][Full Text] [Related]
20. Mesoporous silica/apatite nanocomposite: special synthesis route to control local drug delivery. Sousa A; Souza KC; Sousa EM Acta Biomater; 2008 May; 4(3):671-9. PubMed ID: 18206431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]